125 results
Page 3 of 7
10-K
EX-10.27
h0lgk5n2rtcaz4b
12 Feb 18
Annual report
12:00am
10-K
EX-3.3
w7so76oud
12 Feb 18
Annual report
12:00am
10-K
EX-10.62
eudcxg19labky3pzj
12 Feb 18
Annual report
12:00am
10-K
EX-10.25
hh2e8x4 ji
12 Feb 18
Annual report
12:00am
10-K
EX-10.37
14a7047c352oee9wq527
12 Feb 18
Annual report
12:00am
10-K
EX-10.49
8504sl5p96
12 Feb 18
Annual report
12:00am
10-K
EX-10.50
0swi527ziz3ioojsfm7
12 Feb 18
Annual report
12:00am
10-K
5e2iw
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
wv84u7sllxhy9hlqb0
12 Feb 18
Annual report
12:00am
10-K
EX-10.21
72p45
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
sqvvo13bf6h8ntptrc
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
pkftno57 zu17w3
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
fo5gdyh69
12 Feb 18
Annual report
12:00am
10-K
EX-10.35
lidrzv8tw7et 5b
12 Feb 18
Annual report
12:00am
10-K
EX-10.59
2e22es0mr9h3sviulb6i
12 Feb 18
Annual report
12:00am
424B5
2cxt1lzt9 gn98j
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
dlorlw2c
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am
6-K
EX-99.1
su17f1hs tw
23 Feb 15
Live Filing
12:00am